Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
Wen, Patrick Yung, Rodon, Jordi A, Mason, Warren, Beck, Joseph T, DeGroot, John, Donnet, Valerie, Mills, David, El-Hashimy, Mona, Rosenthal, Mark
Published in ESMO open (12.07.2020)
Published in ESMO open (12.07.2020)
Get full text
Journal Article
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Piha-Paul, Sarina A, Xu, Binghe, Dumbrava, Ecaterina E, Fu, Siqing, Karp, Daniel D, Meric-Bernstam, Funda, Hong, David S, Rodon, Jordi A, Tsimberidou, Apostolia M, Raghav, Kanwal, Ajani, Jaffer A, Conley, Anthony P, Mott, Frank, Fan, Ying, Fan, Jean, Peng, Peng, Wang, Hui, Ni, Shumao, Sun, Caixia, Qiang, Xiaoyan, Levin, Wendy J, Ngo, Brenda, Ru, Qinhua Cindy, Wu, Frank, Javle, Milind M
Published in The oncologist (Dayton, Ohio) (04.04.2024)
Published in The oncologist (Dayton, Ohio) (04.04.2024)
Get full text
Journal Article
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial
How, Jeffrey A., Jazaeri, Amir, Westin, Shannon N., Sood, Anil K., Ramondetta, Lois M., Xu, Mingxuan, Abonofal, Abdulrahman, Karp, Daniel D., Subbiah, Vivek, Stephen, Bettzy, Rodon, Jordi A., Yang, Fei, Naing, Aung
Published in Investigational new drugs (01.06.2021)
Published in Investigational new drugs (01.06.2021)
Get full text
Journal Article
Defining a therapeutic window for the novel TGF‐β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model
Gueorguieva, Ivelina, Cleverly, Ann L., Stauber, Anja, Pillay, N. Sada, Rodon, Jordi A., Miles, Colin P., Yingling, Jonathan M., Lahn, Michael M.
Published in British journal of clinical pharmacology (01.05.2014)
Published in British journal of clinical pharmacology (01.05.2014)
Get full text
Journal Article
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours
Bono, Petri, Massard, Christophe, Peltola, Katriina J, Azaro, Analía, Italiano, Antoine, Kristeleit, Rebecca S, Curigliano, Giuseppe, Lassen, Ulrik, Arkenau, Hendrik-Tobias, Hakulinen, Pasi, Garratt, Chris, Ikonen, Tarja, Mustonen, Mika V J, Rodon, Jordi A
Published in ESMO open (01.12.2020)
Published in ESMO open (01.12.2020)
Get full text
Journal Article
Defining a therapeutic window for the novel TGF ‐β inhibitor LY 2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model
Gueorguieva, Ivelina, Cleverly, Ann L., Stauber, Anja, Pillay, N. Sada, Rodon, Jordi A., Miles, Colin P., Yingling, Jonathan M., Lahn, Michael M.
Published in British journal of clinical pharmacology (01.05.2014)
Published in British journal of clinical pharmacology (01.05.2014)
Get full text
Journal Article